BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 27333182)

  • 21. Monoacylglycerol lipase blockade impairs fine motor coordination and triggers cerebellar neuroinflammation through cyclooxygenase-2.
    Martínez-Torres S; Cutando L; Pastor A; Kato A; Sakimura K; de la Torre R; Valjent E; Maldonado R; Kano M; Ozaita A
    Brain Behav Immun; 2019 Oct; 81():399-409. PubMed ID: 31251974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALS.
    Pasquarelli N; Engelskirchen M; Hanselmann J; Endres S; Porazik C; Bayer H; Buck E; Karsak M; Weydt P; Ferger B; Witting A
    Neuropharmacology; 2017 Sep; 124():157-169. PubMed ID: 28373073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol.
    Ghafouri N; Tiger G; Razdan RK; Mahadevan A; Pertwee RG; Martin BR; Fowler CJ
    Br J Pharmacol; 2004 Nov; 143(6):774-84. PubMed ID: 15492019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocannabinoid metabolism and transport as targets to regulate intraocular pressure.
    Miller S; Daily L; Dharla V; Gertsch J; Malamas MS; Ojima I; Kaczocha M; Ogasawara D; Straiker A
    Exp Eye Res; 2020 Dec; 201():108266. PubMed ID: 32979397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents.
    Wiley JL; Walentiny DM; Wright MJ; Beardsley PM; Burston JJ; Poklis JL; Lichtman AH; Vann RE
    Eur J Pharmacol; 2014 Aug; 737():97-105. PubMed ID: 24858366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain regional cannabinoid CB(1) receptor signalling and alternative enzymatic pathways for 2-arachidonoylglycerol generation in brain sections of diacylglycerol lipase deficient mice.
    Aaltonen N; Riera Ribas C; Lehtonen M; Savinainen JR; Laitinen JT
    Eur J Pharm Sci; 2014 Jan; 51():87-95. PubMed ID: 24012970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects.
    Long JZ; Li W; Booker L; Burston JJ; Kinsey SG; Schlosburg JE; Pavón FJ; Serrano AM; Selley DE; Parsons LH; Lichtman AH; Cravatt BF
    Nat Chem Biol; 2009 Jan; 5(1):37-44. PubMed ID: 19029917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system.
    Chanda PK; Gao Y; Mark L; Btesh J; Strassle BW; Lu P; Piesla MJ; Zhang MY; Bingham B; Uveges A; Kowal D; Garbe D; Kouranova EV; Ring RH; Bates B; Pangalos MN; Kennedy JD; Whiteside GT; Samad TA
    Mol Pharmacol; 2010 Dec; 78(6):996-1003. PubMed ID: 20855465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation.
    Ratano P; Petrella C; Forti F; Passeri PP; Morena M; Palmery M; Trezza V; Severini C; Campolongo P
    Neuropharmacology; 2018 Aug; 138():210-218. PubMed ID: 29842858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of CB
    Karwad MA; Couch DG; Theophilidou E; Sarmad S; Barrett DA; Larvin M; Wright KL; Lund JN; O'Sullivan SE
    FASEB J; 2017 Aug; 31(8):3267-3277. PubMed ID: 28404744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects.
    Kinsey SG; Wise LE; Ramesh D; Abdullah R; Selley DE; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2013 Jun; 345(3):492-501. PubMed ID: 23412396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity.
    Zhang Z; Wang W; Zhong P; Liu SJ; Long JZ; Zhao L; Gao HQ; Cravatt BF; Liu QS
    Hippocampus; 2015 Jan; 25(1):16-26. PubMed ID: 25131612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults.
    Chen X; Zhang J; Chen C
    Neuroscience; 2011 Mar; 178():159-68. PubMed ID: 21256197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy.
    Khasabova IA; Yao X; Paz J; Lewandowski CT; Lindberg AE; Coicou L; Burlakova N; Simone DA; Seybold VS
    Pharmacol Res; 2014 Dec; 90():67-75. PubMed ID: 25304184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.
    Kinsey SG; O'Neal ST; Long JZ; Cravatt BF; Lichtman AH
    Pharmacol Biochem Behav; 2011 Mar; 98(1):21-7. PubMed ID: 21145341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of 2-AG hydrolysis differentially regulates blood brain barrier permeability after injury.
    Piro JR; Suidan GL; Quan J; Pi Y; O'Neill SM; Ilardi M; Pozdnyakov N; Lanz TA; Xi H; Bell RD; Samad TA
    J Neuroinflammation; 2018 May; 15(1):142. PubMed ID: 29759062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents.
    Griebel G; Pichat P; Beeské S; Leroy T; Redon N; Jacquet A; Françon D; Bert L; Even L; Lopez-Grancha M; Tolstykh T; Sun F; Yu Q; Brittain S; Arlt H; He T; Zhang B; Wiederschain D; Bertrand T; Houtmann J; Rak A; Vallée F; Michot N; Augé F; Menet V; Bergis OE; George P; Avenet P; Mikol V; Didier M; Escoubet J
    Sci Rep; 2015 Jan; 5():7642. PubMed ID: 25560837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuronal and Astrocytic Monoacylglycerol Lipase Limit the Spread of Endocannabinoid Signaling in the Cerebellum.
    Chen Y; Liu X; Vickstrom CR; Liu MJ; Zhao L; Viader A; Cravatt BF; Liu QS
    eNeuro; 2016; 3(3):. PubMed ID: 27182552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice.
    Cao Z; Mulvihill MM; Mukhopadhyay P; Xu H; Erdélyi K; Hao E; Holovac E; Haskó G; Cravatt BF; Nomura DK; Pacher P
    Gastroenterology; 2013 Apr; 144(4):808-817.e15. PubMed ID: 23295443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocannabinoid-mediated modulation of Gq/11 protein-coupled receptor signaling-induced vasoconstriction and hypertension.
    Szekeres M; Nádasy GL; Turu G; Soltész-Katona E; Benyó Z; Offermanns S; Ruisanchez É; Szabó E; Takáts Z; Bátkai S; Tóth ZE; Hunyady L
    Mol Cell Endocrinol; 2015 Mar; 403():46-56. PubMed ID: 25595485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.